Search

Author/Creator Balser, Sigrid

2. Safety and efficacy of BI 695501 versus adalimumab reference product in patients with advanced Crohn's disease (VOLTAIRE-CD): a multicentre, randomised, double-blind, phase 3 trial. (October 2021)

Authors:
Hanauer, Stephen; Liedert, Bernd; Balser, Sigrid; Brockstedt, Ekkehard; Moschetti, Viktoria; Schreiber, Stefan
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 6:Number 10(2021)
Page Start:
816
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Similar efficacy, safety, and immunogenicity of the biosimilar BI 695501 and adalimumab reference product in patients with moderate-to-severe chronic plaque psoriasis: results from the randomized Phase III VOLTAIRE-PSO study. (2nd January 2021)

Authors:
Menter, Alan; Arenberger, Petr; Balser, Sigrid; Beissert, Stefan; Cauthen, Ashley; Czeloth, Niklas; Soung, Jennifer; Jazayeri, Sasha; Weisenseel, Peter; Jayadeva, Girish
Journal:
Expert opinion on biological therapy
Issue:
Volume 21:Number 1(2021)
Page Start:
87
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗